Affinage

PLCXD2

PI-PLC X domain-containing protein 2 · UniProt Q0VAA5

Length
305 aa
Mass
34.8 kDa
Annotated
2026-06-10
2 papers in source corpus 2 papers cited in narrative 3 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PLCXD2 is a constitutively active phospholipase C family member that functions in postsynaptic signaling to control dendritic spine maturation (PMID:40393451). In mouse cortical neurons, PLCXD2 forms a complex with the postsynaptic GPCR GPR158, which directly restrains its activity; when this restraint is lost, unrestrained PLCXD2 activity impedes incorporation of the spine apparatus into dendritic spines and blocks structural and functional spine maturation (PMID:40393451). Binding of extracellular heparan sulfate proteoglycans modulates the GPR158-PLCXD2 interaction, defining a direct receptor-to-PLC signaling route that operates independently of canonical G-protein-mediated PLC activation (PMID:40393451). At the post-transcriptional level, PLCXD2 mRNA is directly repressed by miR-378a-3p, and the lncRNA ACTA2-AS1 sequesters this microRNA as a competing endogenous RNA to de-repress PLCXD2 in gastric cancer cells (PMID:35274046). Beyond these findings, the catalytic substrate specificity and structural basis of PLCXD2 regulation have not been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2022 Medium

    Established a post-transcriptional control axis for PLCXD2, answering how its expression level is set in a disease context.

    Evidence RNA pulldown, luciferase reporter, RIP, and knockdown rescue assays in gastric cancer cells

    PMID:35274046

    Open questions at the time
    • Single lab; mechanism connecting PLCXD2 level to the cancer phenotype not resolved
    • No link drawn between this regulatory axis and PLCXD2 catalytic or neuronal function
  2. 2025 High

    Defined PLCXD2 as a constitutively active PLC whose unrestrained activity blocks spine apparatus incorporation and dendritic spine maturation, identifying its functional role in postsynaptic biology.

    Evidence Sparse in vivo loss-of-function genetic manipulation of mouse cortical neurons with spine apparatus and spine maturation readouts

    PMID:40393451

    Open questions at the time
    • Substrate and lipid second-messenger output of PLCXD2 not defined
    • Downstream effectors linking PLCXD2 activity to spine apparatus incorporation unknown
  3. 2025 Medium

    Showed that GPR158 directly restrains PLCXD2 and that heparan sulfate proteoglycan binding tunes this interaction, establishing a non-canonical GPCR-to-PLC pathway bypassing G proteins.

    Evidence Complex identification and functional epistasis in cortical neurons in vivo with HSPG modulation

    PMID:40393451

    Open questions at the time
    • HSPG modulation mechanism not reconstituted biochemically
    • Structural basis of the GPR158-PLCXD2 interaction not determined
    • Single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • The catalytic substrate, lipid products, and structural mechanism by which GPR158 inhibits PLCXD2 remain undefined.
  • No in vitro reconstitution of PLCXD2 enzymatic activity
  • No structural model of the inhibitory complex

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140098 catalytic activity, acting on RNA 1
Pathway
R-HSA-162582 Signal Transduction 2
Partners
Complex memberships
GPR158-PLCXD2 postsynaptic signaling complex

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2025 PLCXD2 is a constitutively active phospholipase C (PLC) family member that forms a postsynaptic signaling complex with the GPCR GPR158; unrestrained PLCXD2 activity (in the absence of GPR158) impedes spine apparatus (SA) incorporation into dendritic spines and hampers structural and functional dendritic spine maturation in mouse cortical neurons in vivo. Sparse genetic manipulations (loss-of-function) of mouse cortical neurons in vivo; identification of GPR158-PLCXD2 complex; functional readouts of spine apparatus abundance and dendritic spine maturation Developmental cell High 40393451
2025 GPR158 restrains PLCXD2 activity by direct interaction, and extracellular heparan sulfate proteoglycan (HSPG) binding modulates the GPR158-PLCXD2 interaction, providing spatiotemporal control over GPR158 signaling; this represents a direct GPCR-like receptor-to-PLC signaling pathway that bypasses canonical PLC regulation via G proteins. Complex identification and functional epistasis in cortical neurons in vivo; HSPG binding modulation of the GPR158-PLCXD2 interaction Developmental cell Medium 40393451
2022 PLCXD2 mRNA is a direct target of miR-378a-3p, which suppresses its expression; the lncRNA ACTA2-AS1 acts as a competing endogenous RNA (ceRNA) to sequester miR-378a-3p and thereby de-repress PLCXD2 expression in gastric cancer cells. RNA pulldown assays, luciferase reporter assays, RNA immunoprecipitation assays, PLCXD2 knockdown rescue experiments Open medicine (Warsaw, Poland) Medium 35274046

Source papers

Stage 0 corpus · 2 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2022 lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells. Open medicine (Warsaw, Poland) 8 35274046
2025 A postsynaptic GPR158-PLCXD2 complex controls spine apparatus abundance and dendritic spine maturation. Developmental cell 4 40393451

Missed literature

Know a paper Affinage missed for PLCXD2? Flag it for the maintainers and the community.

No submissions yet.